Vilacto Bio (Vilacto Bio) Accounts Payable & Accrued Expense : $0.28 Mil (As of Jun. 2019)

View and export this data going back to 2013. Start your Free Trial

What is Vilacto Bio Accounts Payable & Accrued Expense?

Vilacto Bio's quarterly accounts payable & accrued expense increased from Dec. 2018 ($0.24 Mil) to Mar. 2019 ($0.25 Mil) and increased from Mar. 2019 ($0.25 Mil) to Jun. 2019 ($0.28 Mil).

Vilacto Bio's annual accounts payable & accrued expense increased from Mar. 2017 ($0.01 Mil) to Mar. 2018 ($0.28 Mil) but then declined from Mar. 2018 ($0.28 Mil) to Mar. 2019 ($0.25 Mil).

Vilacto Bio Accounts Payable & Accrued Expense Historical Data

The historical data trend for Vilacto Bio's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilacto Bio Accounts Payable & Accrued Expense Chart

Vilacto Bio Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.01

0.03

0.01

0.28

0.25

Vilacto Bio Quarterly Data
	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.29	0.22	0.24	0.25	0.28

Vilacto Bio Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Vilacto Bio (Vilacto Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vilacto Bio Inc (GREY:VIBI) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Fabriksvej 48, Suite 2607, The Seagram Building, Naestved, DNK, 4700

Website

https://www.vilacto.com

Vilacto Bio Inc is a biotech company. It operates a fully patented Lactoactive molecule for treating conditions such as inflammatory diseases, diabetics, psoriasis, and skin issues in different levels. The company is also intended to develop Lactoactive molecule for increasing the quality of its retail and medical skin cream product as well as developing products for medical applications. Its product portfolio includes lotions, skin care creams and gels, lip balms, foot creams and oils, and others.